Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27803315)

Published in Physiol Rep on November 01, 2016

Authors

Narihito Tatsumoto1,2, Masaki Arioka3, Shunsuke Yamada2, Fumi Takahashi-Yanaga1,4, Masanori Tokumoto5, Kazuhiko Tsuruya2,6, Takanari Kitazono2, Toshiyuki Sasaguri1

Author Affiliations

1: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
2: Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
3: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan arioka@clipharm.med.kyushu-u.ac.jp.
4: Global Medical Science Education Unit, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
5: Department of Internal Medicine, Fukuoka Dental College, Fukuoka, Japan.
6: Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles cited by this

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res (2010) 9.95

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 8.37

Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J (1990) 6.23

Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet (2015) 4.83

Lithium toxicity profile: a systematic review and meta-analysis. Lancet (2012) 4.82

WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med (2013) 4.52

Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell (2007) 4.39

High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int (2013) 3.30

Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29

Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27

Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A (2005) 2.67

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun (2001) 2.08

Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int (2003) 2.02

Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92

Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91

GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol (2010) 1.85

Animal model of adenine-induced chronic renal failure in rats. Nephron (1986) 1.80

Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest (2008) 1.76

Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76

Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74

Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res (2006) 1.63

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone (2003) 1.60

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res (2012) 1.55

Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis (2004) 1.54

Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res (2011) 1.53

Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation. Bone (2013) 1.48

Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res (2006) 1.44

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26

GSK-3α is a central regulator of age-related pathologies in mice. J Clin Invest (2013) 1.25

Activator or inhibitor? GSK-3 as a new drug target. Biochem Pharmacol (2013) 1.25

Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol (2004) 1.23

Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res (2010) 1.16

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int (2008) 1.14

GSK-3beta is required for memory reconsolidation in adult brain. PLoS One (2008) 1.11

Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05

Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol (2011) 1.04

Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int (2014) 1.03

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol (2014) 0.99

Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency. Bone (1998) 0.98

Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res (2015) 0.98

GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity. J Am Soc Nephrol (2010) 0.98

Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice. Kidney Int (2012) 0.98

Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. Kidney Int (2012) 0.98

Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis (2003) 0.96

Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res (2015) 0.95

Changing bone patterns with progression of chronic kidney disease. Kidney Int (2016) 0.93

p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone (2013) 0.88

Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant (2008) 0.88

A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol (2013) 0.88

Role of TGF-β in a mouse model of high turnover renal osteodystrophy. J Bone Miner Res (2014) 0.85

Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models. BMC Nephrol (2014) 0.85

Uremic osteoporosis. Kidney Int Suppl (2011) (2013) 0.83

Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis. Biochem Pharmacol (2014) 0.83

Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium. Am J Physiol Renal Physiol (2012) 0.83

GSK-3 inhibition by an orally active small molecule increases bone mass in rats. Bone (2011) 0.82

Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice. Am J Physiol Renal Physiol (2015) 0.81

Acceleration of bone development and regeneration through the Wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β. Biochem Biophys Res Commun (2013) 0.81

Bone strength: more than just bone density. Kidney Int (2016) 0.79

Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients. Clin J Am Soc Nephrol (2010) 0.78

Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation. J Bone Miner Metab (2013) 0.77

ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways. Exp Cell Res (2015) 0.77

High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. Nephrol Dial Transplant (2012) 0.77

Articles by these authors

Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial. Clin Gastroenterol Hepatol (2015) 1.44

The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res (2012) 0.94

U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Metabolism (2013) 0.88

Midlife and Late-Life Smoking and Risk of Dementia in the Community: The Hisayama Study. J Am Geriatr Soc (2015) 0.87

Relationship between salt intake as estimated by a brief self-administered diet-history questionnaire (BDHQ) and 24-h urinary salt excretion in hypertensive patients. Hypertens Res (2015) 0.84

Midlife and late-life handgrip strength and risk of cause-specific death in a general Japanese population: the Hisayama Study. J Epidemiol Community Health (2014) 0.83

Impact of leisure-time physical activity on glycemic control and cardiovascular risk factors in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PLoS One (2014) 0.83

Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis. Biochem Pharmacol (2014) 0.83

Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism. Clin Exp Nephrol (2009) 0.83

Nonconvulsive partial status epilepticus mimicking recurrent infarction revealed by diffusion-weighted and arterial spin labeling perfusion magnetic resonance images. J Stroke Cerebrovasc Dis (2015) 0.83

Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension. Hypertens Res (2014) 0.82

Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance Registry. J Stroke Cerebrovasc Dis (2014) 0.82

Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease. Hypertens Res (2013) 0.82

Effects of smoking and its cessation on creatinine- and cystatin C-based estimated glomerular filtration rates and albuminuria in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Hypertens Res (2016) 0.81

Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease. Kidney Int (2014) 0.81

Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis. Hypertens Res (2014) 0.81

Dose- and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PLoS One (2015) 0.81

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. PLoS Genet (2015) 0.79

Recurrent sarcoidosis with psoas muscle granuloma and hypercalcaemia in a patient on chronic haemodialysis. Nephrology (Carlton) (2009) 0.79

Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study. Atherosclerosis (2014) 0.79

Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice. Life Sci (2014) 0.79

Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study. PLoS One (2015) 0.78

Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial. Clin Exp Nephrol (2016) 0.78

Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population. Am J Kidney Dis (2015) 0.78

Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry. PLoS One (2015) 0.78

Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors. Hypertens Res (2013) 0.78

Brain atrophy in peritoneal dialysis and CKD stages 3-5: a cross-sectional and longitudinal study. Am J Kidney Dis (2014) 0.77

The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis. Clin Endocrinol (Oxf) (2013) 0.77

Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis. Nephrology (Carlton) (2015) 0.77

Detrimental role of pericyte Nox4 in the acute phase of brain ischemia. J Cereb Blood Flow Metab (2015) 0.76

Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study. Am J Kidney Dis (2017) 0.76

Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis. CEN Case Rep (2014) 0.75

Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism. Ther Apher Dial (2015) 0.75

A case of bacterial peritonitis caused by Roseomonas mucosa in a patient undergoing continuous ambulatory peritoneal dialysis. CEN Case Rep (2013) 0.75

2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation. Hypertens Res (2016) 0.75

Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomy. CEN Case Rep (2016) 0.75

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis. Case Rep Neurol (2016) 0.75

Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway. Cancer Sci (2016) 0.75

Extrapulmonary tuberculosis presented as fever of unknown origin in two patients with endstage kidney disease not on dialysis: usefulness of 18-FDG-PET/CT in the diagnostic localization of fever of unknown origin. CEN Case Rep (2015) 0.75

Cerebral Venous Thrombosis in the Superior Sagittal Sinus as a Rare Cause of a Paroxysmal Kinetic Tremor. Case Rep Neurol (2017) 0.75

De novo myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis 31 years after living-donor kidney transplantation. CEN Case Rep (2014) 0.75

Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study. PLoS One (2015) 0.75

New-onset systemic lupus erythematosus in a long-term hemodialysis patient with acute pleuritis and pneumonitis. CEN Case Rep (2014) 0.75

Clinical characteristics of type A acute aortic dissection with symptom of the central nervous system. Am J Emerg Med (2017) 0.75

Successful initiation and maintenance of hemodialysis in an adult patient with complete transposition of the great arteries. Clin Exp Nephrol (2010) 0.75

Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use. Calcif Tissue Int (2016) 0.75

Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke (2016) 0.75

Dura mater graft-associated Creutzfeldt-Jakob disease with 30-year incubation period. Neuropathology (2016) 0.75

Modified Creatinine Index and the Risk of Bone Fracture in Patients Undergoing Hemodialysis: The Q-Cohort Study. Am J Kidney Dis (2017) 0.75

Influenza Vaccination and Other Factors Related to the Development of Influenza-Like Illness Among Patients on Chronic Hemodialysis in a Japanese Dialysis Facility. Ther Apher Dial (2016) 0.75

Arginase 2 is a mediator of ischemia-reperfusion injury in the kidney through regulation of nitrosative stress. Kidney Int (2020) 0.75

Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction. Lab Invest (2017) 0.75

Celecoxib inhibits osteoblast maturation by suppressing the expression of Wnt target genes. J Pharmacol Sci (2016) 0.75

Prognostic value of chromosomal translocations in small-bowel diffuse large B-cell lymphoma. Histopathology (2015) 0.75

Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy. Clin Exp Nephrol (2015) 0.75

Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy. Nephrol Dial Transplant (2017) 0.75

The potential role of perivascular lymphatic vessels in preservation of kidney allograft function. Clin Exp Nephrol (2016) 0.75

Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats. Life Sci (2016) 0.75

Repeated Paradoxical Brain Infarctions in a Patient on Self-Managed Home Hemodialysis Using a Long-Term Indwelling Catheter. J Stroke Cerebrovasc Dis (2017) 0.75

A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study. J Neurol Sci (2015) 0.75

Asymptomatic Brain Edema after Hemodialysis Initiation in a Patient with Severe Uremia. Case Rep Med (2017) 0.75

Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant (2017) 0.75

Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion. Biochem Pharmacol (2017) 0.75

Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells. Biochem Pharmacol (2016) 0.75

Disruption of xanthine oxidoreductase gene attenuates renal ischemia reperfusion injury in mice. Life Sci (2017) 0.75

Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials. Nephrology (Carlton) (2017) 0.75

Hypercalcemia and large abdominal mass. NDT Plus (2011) 0.75

Inorganic phosphate-induced impairment of osteoclast cell-cell fusion by the inhibition of AP-1-mediated DC-STAMP expression. Biochem Biophys Res Commun (2017) 0.75

Hypercalcaemia-induced acute kidney injury in an older patient with osteoporosis treated with alfacalcidol for denosumab-induced hypocalcaemia. Nephrology (Carlton) (2017) 0.75

Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy. Clin Exp Nephrol (2016) 0.75

The Fukuoka Kidney disease Registry (FKR) Study: design and methods. Clin Exp Nephrol (2016) 0.75

Association of Hypertriglyceridemia With the Incidence and Progression of Chronic Kidney Disease and Modification of the Association by Daily Alcohol Consumption. J Ren Nutr (2017) 0.75

Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L. Ther Apher Dial (2015) 0.75

Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study. Gut Liver (2017) 0.75

Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack. Cerebrovasc Dis (2019) 0.75

MODIFIED SIMPLE PERITONEAL WALL ANCHOR TECHNIQUE (PWAT) IN PERITONEAL DIALYSIS. Perit Dial Int (2016) 0.75

Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke. J Neurol Sci (2014) 0.75

Pseudohyperchloraemia caused by long-term use of analgesic containing bromovaleryl urea. Nephrology (Carlton) (2016) 0.75

A J-shaped association between serum uric acid levels and poor renal survival in female patients with IgA nephropathy. Hypertens Res (2016) 0.75

Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats. J Am Heart Assoc (2017) 0.75